Publications by authors named "Niurka Colina"
Article Synopsis
- The study tested the combination of pentoxifylline (PTX) and vedolizumab (VDZ) against VDZ alone in adults with Crohn's disease to see if it was safer and more effective over 24 weeks.
- Results showed no significant difference in clinical or endoscopic remission rates between the two groups, but the PTX group had improved clinical responses and reduced tumor necrosis factor (TNF) levels.
- The authors concluded that while the combination treatment didn’t outperform VDZ monotherapy in overall remission, it appeared safe and demonstrated some benefits, suggesting further research should be conducted.
Alzheimer's disease (AD) is a leading killer of Americans, imparts a significant toll on the quality of life of the patient and primary caregiver, and results in inordinate costs in an already overburdened medical system. Prior studies on cholinesterase inhibitors among AD patients have shown minimal amelioration of disease symptoms and/or restoration of lost cognitive functioning. The effect of improved nutrition, particularly with dietary supplements, on cognitive functioning may offer an alternative strategy compared to standard treatment.
View Article and Find Full Text PDF